Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen May Lin Oh

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Travel Medicine|August 14, 2009
Chikungunya in Singapore: imported cases among travelers visiting friends and relativesPoh Lian Lim, Helen May-Lin Oh, Eng Eong Ooi
Human Vaccines & Immunotherapeutics|February 2, 2023
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccinesMoe H Kyaw, Julia Spinardi, Ling Zhang, et al.
Medical Mycology Case Reports|March 31, 2021
Negative cerebrospinal fluid β-d-glucan levels as an indicator for treatment cessation ahead of biochemical resolution: A case report of <i>Candida glabrata</i> meningitisLiang En Wee, Crystal Shie Lyeen Wong, Ai Ling Tan, et al.
Vaccines|November 27, 2021
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 VaccineChin-Shern Lau, Soon Kieng Phua, Ya-Li Liang, et al.
Frontiers in Public Health|October 11, 2023
Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in AsiaKaran Thakkar, Julia Regazzini Spinardi, Jingyan Yang, et al.
Vaccine|August 18, 2009
Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adultsDaniel Wai-Sing Chu, Shinn-Jang Hwang, Fong Seng Lim, et al.
Vaccine|November 28, 2017
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trialTing Fan Leung, Anthony Pak-Yin Liu, Fong Seng Lim, et al.
Journal of Neurovirology|April 29, 2015
Neurology of the H1N1 pandemic in Singapore: a nationwide case series of children and adultsAsha Prerna, Jocelyn Y X Lim, Natalie W H Tan, et al.
Human Vaccines & Immunotherapeutics|June 11, 2015
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trialTing Fan Leung, Anthony Pak-Yin Liu, Fong Seng Lim, et al.
Emerging Infectious Diseases|June 17, 2015
Severe Pediatric Adenovirus 7 Disease in Singapore Linked to Recent Outbreaks across AsiaOon-Tek Ng, Koh Cheng Thoon, Hui Ying Chua, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Travel Medicine|August 14, 2009
Chikungunya in Singapore: imported cases among travelers visiting friends and relativesPoh Lian Lim, Helen May-Lin Oh, Eng Eong Ooi
Human Vaccines & Immunotherapeutics|February 2, 2023
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccinesMoe H Kyaw, Julia Spinardi, Ling Zhang, et al.
Medical Mycology Case Reports|March 31, 2021
Negative cerebrospinal fluid β-d-glucan levels as an indicator for treatment cessation ahead of biochemical resolution: A case report of <i>Candida glabrata</i> meningitisLiang En Wee, Crystal Shie Lyeen Wong, Ai Ling Tan, et al.
Vaccines|November 27, 2021
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 VaccineChin-Shern Lau, Soon Kieng Phua, Ya-Li Liang, et al.
Frontiers in Public Health|October 11, 2023
Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in AsiaKaran Thakkar, Julia Regazzini Spinardi, Jingyan Yang, et al.
Vaccine|August 18, 2009
Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adultsDaniel Wai-Sing Chu, Shinn-Jang Hwang, Fong Seng Lim, et al.
Vaccine|November 28, 2017
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trialTing Fan Leung, Anthony Pak-Yin Liu, Fong Seng Lim, et al.
Journal of Neurovirology|April 29, 2015
Neurology of the H1N1 pandemic in Singapore: a nationwide case series of children and adultsAsha Prerna, Jocelyn Y X Lim, Natalie W H Tan, et al.
Human Vaccines & Immunotherapeutics|June 11, 2015
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trialTing Fan Leung, Anthony Pak-Yin Liu, Fong Seng Lim, et al.
Emerging Infectious Diseases|June 17, 2015
Severe Pediatric Adenovirus 7 Disease in Singapore Linked to Recent Outbreaks across AsiaOon-Tek Ng, Koh Cheng Thoon, Hui Ying Chua, et al.
Pageof 1